Therma Bright Inc - TBRIF STOCK NEWS

Therma Bright (TSXV: THRM, OTCQB: TBRIF) announced it has completed debt settlements by issuing 19,250,000 common shares at $0.01 per share, settling an aggregate debt of $192,500. These shares are subject to a hold period until October 20, 2024. CEO Rob Fia participated in the debt settlement, receiving 8,500,000 shares for $85,000 of debt, which is a related party transaction under MI 61-101. Prior to this, Fia owned 28,718,744 shares (7.2% of Therma's outstanding shares). Post-transaction, he now owns 37,218,744 shares, representing 8.8% of the total outstanding shares. On a partially diluted basis, Fia's ownership could rise to 13.3%. Fia's acquisition is for investment purposes and he may change his holdings in the future. Further details can be found on SEDAR+.

Therma Bright has completed the first tranche of its non-brokered private placement, raising $854,500 by issuing 85,450,000 units at $0.01 each. The proceeds will fund investments in Digital Cough Technology and InStatin Inc, cover management and director debts, investor relations, and general working capital. CEO Rob Fia purchased 17,500,000 units for $175,000, increasing his stake to 7.2%. Allele Communications will provide investor relations services for $7,500 per month under a new consulting agreement. The securities are subject to a hold period until October 11, 2024.

Therma Bright, a developer of diagnostic and medical device technologies, announces a non-brokered private placement offering up to $1,000,000 by issuing 100,000,000 units at $0.01 per unit. Each unit includes one common share and a half-warrant, with full warrants exercisable over three years at $0.05 in the first year and $0.10 in the subsequent years. The proceeds will fund their Digital Cough technology, pay debts, and support general working capital. The offering is expected to close by June 7, 2024, pending regulatory approvals. Additionally, Therma Bright has granted stock options and warrants to directors, officers, consultants, and entered into debt settlements issuing common shares.

Therma Bright Inc. (TBRIF) initiates a strategic review process to enhance shareholder value. The Board will explore various alternatives, including strategic partnerships, acquisitions, or spin-offs. The company also finalizes an 8.44% equity holding in Inretio for its Preva™ Ischemic stroke device.

Therma Bright Inc. (TBRIF) will resume trading on the TSXV on February 7, 2024. The company received a letter from the Center of Medicare and Medicaid regarding its Venowave device, confirming the reopening of its application for securing permanent CPT/HCPCS codes. This is a positive development for the company's medical device technologies. Additionally, Therma Bright has received notification from the TSXV about the resumption of stock trading.

Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) has received a cease trade order from the Ontario Securities Commission for not filing annual financial statements and management's discussion and analysis by the periodic disclosure deadline. The company is working with its new auditor to finalize the documents and aims to file them soon, expecting no lengthy delay.

Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX) has announced that its AI-driven Digital Cough Analyzer (DCA) developed in partnership with AI4LYF, is ready for a 513(g) request to the U.S. FDA. The DCA offers advanced features for patients and medical practitioners, aiming to revolutionize remote therapeutic monitoring (RTM) solutions. The technology has the potential to diagnose various health issues through cough data analysis, making it a groundbreaking innovation in healthcare.

Therma Bright Inc. has opened its distribution channels for its Venowave device, with multiple partners expressing interest in evaluating its commerciality. Pilot units have been shipped to each partner for patient pilot tests.

Therma Bright Inc. appoints Eric Myung as CFO, replacing Victor Hugo. Myung has extensive experience in financial analysis and has worked as CFO for several TSX Venture Exchange companies. The CEO welcomes Myung and Marrelli Support Services to the team.